Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines

Clinical trial NCT01144663 · COMPLETED

Trial details

NCT number: NCT01144663
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Meningococcal Meningococcal Vaccines

Start date: 2010-07-01
Primary completion: 2012-06-22
Enrollment: 2095

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.